495 related articles for article (PubMed ID: 35618286)
1. Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma.
Yu Z; Li Y; Li Y; Zhang J; Li M; Ji L; Tang Y; Zheng Y; Sheng J; Han Q; Li F; Guo J; Wang L; Sun X; Gao Y; Feng H
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618286
[TBL] [Abstract][Full Text] [Related]
2. Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling.
Zhang X; Lu X; Shi J; Li Y; Li Y; Tao R; Huang L; Tang Y; Zhu X; Li M; Gao Y; Feng H; Yu Z
Phytomedicine; 2024 Apr; 126():155395. PubMed ID: 38340578
[TBL] [Abstract][Full Text] [Related]
3. Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages.
Ou DL; Chen CW; Hsu CL; Chung CH; Feng ZR; Lee BS; Cheng AL; Yang MH; Hsu C
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753566
[TBL] [Abstract][Full Text] [Related]
4. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
[TBL] [Abstract][Full Text] [Related]
5. Extracts of Cordyceps sinensis inhibit breast cancer growth through promoting M1 macrophage polarization via NF-κB pathway activation.
Li J; Cai H; Sun H; Qu J; Zhao B; Hu X; Li W; Qian Z; Yu X; Kang F; Wang W; Zou Z; Gu B; Xu K
J Ethnopharmacol; 2020 Oct; 260():112969. PubMed ID: 32422358
[TBL] [Abstract][Full Text] [Related]
6. CD8
Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
[TBL] [Abstract][Full Text] [Related]
7. Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response.
Wang YN; Wang YY; Wang J; Bai WJ; Miao NJ; Wang J
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37652576
[TBL] [Abstract][Full Text] [Related]
8. Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinoma.
Gao Z; Li XG; Feng SR; Chen JF; Song K; Shi YH; Tang Z; Liu WR; Zhang X; Huang A; Luo XM; Zeng HY; Gao Q; Shi GM; Ke AW; Zhou J; Fan J; Fu XT; Ding ZB
Int Immunopharmacol; 2023 Oct; 123():110685. PubMed ID: 37494837
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signaling.
Wang H; Zhang C; Chi H; Meng Z
Int J Oncol; 2018 Jun; 52(6):2051-2060. PubMed ID: 29620259
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway.
Min L; Wang H; Qi H
Am J Transl Res; 2022; 14(3):1551-1566. PubMed ID: 35422920
[TBL] [Abstract][Full Text] [Related]
11. Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase.
Yu Z; Feng H; Sun X; Zhuo Y; Li M; Zhou Z; Huang L; Jiang Y; Zhu X; Zhang X; Le F; Zheng C; Cheng AS; Gao Y
Sci Rep; 2018 Mar; 8(1):3891. PubMed ID: 29497076
[TBL] [Abstract][Full Text] [Related]
12. The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation.
Luo F; Li H; Ma W; Cao J; Chen Q; Lu F; Qiu M; Zhou P; Xia Z; Zeng K; Zhan J; Zhou T; Luo Q; Pan W; Zhang L; Lin C; Huang Y; Zhang L; Yang D; Zhao H
Cell Mol Immunol; 2024 Jan; 21(1):60-79. PubMed ID: 38062129
[TBL] [Abstract][Full Text] [Related]
13. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
14. Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization.
Xu G; Feng D; Yao Y; Li P; Sun H; Yang H; Li C; Jiang R; Sun B; Chen Y
Oncogene; 2020 Feb; 39(7):1429-1444. PubMed ID: 31659256
[TBL] [Abstract][Full Text] [Related]
15. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
Zhu Y; Yang J; Xu D; Gao XM; Zhang Z; Hsu JL; Li CW; Lim SO; Sheng YY; Zhang Y; Li JH; Luo Q; Zheng Y; Zhao Y; Lu L; Jia HL; Hung MC; Dong QZ; Qin LX
Gut; 2019 Sep; 68(9):1653-1666. PubMed ID: 30902885
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma.
Weng J; Liu S; Zhou Q; Xu W; Xu M; Gao D; Shen Y; Yi Y; Shi Y; Dong Q; Zhou C; Ren N
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37385725
[TBL] [Abstract][Full Text] [Related]
17. Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice.
Zhang ZJ; Yang YK; Wu WZ
J Transl Med; 2014 Feb; 12():57. PubMed ID: 24581171
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype.
Chen D; Xie J; Fiskesund R; Dong W; Liang X; Lv J; Jin X; Liu J; Mo S; Zhang T; Cheng F; Zhou Y; Zhang H; Tang K; Ma J; Liu Y; Huang B
Nat Commun; 2018 Feb; 9(1):873. PubMed ID: 29491374
[TBL] [Abstract][Full Text] [Related]
19. Progranulin inhibits LPS-induced macrophage M1 polarization via NF-кB and MAPK pathways.
Liu L; Guo H; Song A; Huang J; Zhang Y; Jin S; Li S; Zhang L; Yang C; Yang P
BMC Immunol; 2020 Jun; 21(1):32. PubMed ID: 32503416
[TBL] [Abstract][Full Text] [Related]
20. The anti-hepatocellular carcinoma effects of polysaccharides from
Li GL; Tang JF; Tan WL; Zhang T; Zeng D; Zhao S; Ran JH; Li J; Wang YP; Chen DL
Food Funct; 2023 Apr; 14(7):3155-3168. PubMed ID: 36883482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]